High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Disease: Outcome Based on a Prognostic Model

Publisher： Karger

E-ISSN： 1421-9662|110|4|173-178

ISSN： 0001-5792

Source： Acta Haematologica, Vol.110, Iss.4, 2003-12, pp. : 173-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma

By  

PEDIATRIC TRANSPLANTATION, Vol. 1397-3142, Iss. 7, 2015-11 ,pp. : 745-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐dose therapy and autologous stem cell transplantation for children with HIV‐associated non‐Hodgkin lymphoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 984-987

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine in the Treatment of Relapsed and Refractory Hodgkin’s Disease

By  

Oncology Research and Treatment, Vol. 28, Iss. 11, 2005-10 ,pp. : 567-571

Karger

Access to resources Recommend Favorite

The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed hodgkin lymphoma

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 380-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Infectious Complications after High-Dose Therapy and Autologous Blood Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 491-496

Karger

Access to resources Recommend Favorite